TCID
TCID is a potent and selective inhibitor of ubiquitin C-terminal hydrolase L3 (UCH-L3) with an IC50 of 0.6 μM, demonstrating 125-fold selectivity over UCH-L1. This small molecule probe is used in biochemical and cellular studies to investigate deubiquitinase function, protein homeostasis, and related disease pathways in vitro.
Product Specifications
CAS Number
30675-13-9
Product Name Alternative
C-terminal, DUBs, Deubiquitinase, glycine, GlyT2, hydrolase, Inhibitor, inhibit, Neuronal, TCID, UCH-L1, UCH-L3 Inhibitor, UCH-L3, ubiquitination, ubiquitin, transporter
Field of Research
Cancer Biology, Protein Biochemistry
Purity
>98%
Bioactivity
DUB inhibitor
Form
Powder
Solubility
Soluble in DMSO (up to 25 mg/ml)
Smiles
Clc1c2C (=O) CC (=O) c2c (Cl) c (Cl) c1Cl
Molecular Formula
C9H2Cl4O2
Molecular Weight
283.93
Storage Conditions
RT
Notes
For research use only.
Other Product Names
4,5,6,7-Tetrachloro-1H-indene-1,3 (2H) -dione
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15328115 1 Vial
Lentiviral human MYH1 shRNA (UAS) - Lentiviral human MYH1 shRNA (UAS, GFP) (25)
Sign In for Pricing
View Details 